European HIV Cohorts


The Mission of COHERE, a structure organised in 2005, is to conduct epidemiological research on the prognosis and outcome of HIV-infections in people from across Europe including pregnant mothers, children, and adults. The research focuses on scientific questions requiring a large sample size of patients which the contributing cohorts answer individually and which do not overlap with existing collaborations bewteen participating COHERE cohorts.

Go to website ...


D:A:D Study

The Data Collection o­n Adverse events of Anti-HIV Drugs (D:A:D) is a prospective multicohort study of HIV-infected persons under active follow up. The purpose of the study is to assess the incidence of myocardial infarction among HIV-infected and AIDS patients who are receiving antiretroviral therapy. This, in turn, will allow to investigate whether treatment with anti-retroviral drugs is associated with development of cardiovascular disease, and other long-term side effects.

Go to website ...



The European Coordinating Committee for the Integration of Ongoing Coordination Actions Related to Clinical and Epidemiological HIV Research, or EuroCoord, was set up on 6 February 2006 for the purpose of integrating the projects across the partners and to coordinate the submission of funding applications for the seventh EU Framework Program.

EuroCoord comprises a cooperation initiative taken by leaders representing the following four projects: CASCADE, COHERE, EuroSIDA, PENTA.

Go to website ...


EuroSIDA Study

The EuroSIDA study is a prospective observational cohort study of more than 16.505 patients followed in 103 hospitals in 32 European countries plus Israel and Argentina. The main objective of the study is to assess the impact of antiretroviral drugs o­n the outcome of the general population of HIV-infected patients living in Europe.
Go to website ...